No single recreational drug has been conclusively shown to cause autism spectrum disorder (ASD) in human offspring. The relationship between prenatal substance exposure and autism is far murkier than headlines suggest, tangled up in genetics, confounding variables, and the sheer difficulty of studying drug use during pregnancy. Environmental factors may account for roughly half the variation in autism risk, but “environmental” is a sprawling category that includes everything from infections to air pollution to parental age.1Current Medicinal Chemistry. Environmental Risk Factors in Autism Spectrum Disorder: A Narrative Review Where specific drugs fit within that picture depends heavily on which substance you ask about, how much exposure occurred, and how well the study controlled for other explanations.
Why This Question Is So Hard to Answer
Before looking at any specific drug, it helps to understand why the science on prenatal substance exposure and autism remains so frustratingly inconclusive. Researchers face a tangle of problems that make it difficult to isolate the effect of any one substance. People who use drugs during pregnancy often use more than one substance simultaneously. They may also face poverty, poor nutrition, limited prenatal care, untreated mental health conditions, and higher levels of stress, all of which can independently affect fetal brain development.2PubMed Central. Methodological Issues in Assessing the Impact of Prenatal Drug Exposure Separating the drug’s effect from all of that background noise is the central challenge.
There is also the problem of measurement. Self-reported drug use during pregnancy is notoriously unreliable, for obvious reasons. Women underreport use due to stigma and legal fears. The dose, timing, and duration of exposure vary enormously between individuals, and small differences in any of these variables could mean the difference between a real biological effect and none at all.2PubMed Central. Methodological Issues in Assessing the Impact of Prenatal Drug Exposure On top of all that, some effects of prenatal exposure may not become apparent until years later, making it hard to trace them back to their origin.
One particularly thorny issue is genetic confounding. A large study published in Nature Medicine found that many of the observed associations between maternal health conditions and offspring autism could be explained by shared genetic factors within families rather than by direct prenatal effects.3PubMed Central. Familial confounding in the associations between maternal health and autism In other words, the same genetic variants that increase a parent’s vulnerability to substance use disorders might independently increase their child’s likelihood of developing autism, creating a statistical association that looks causal but is not. Sibling comparison studies, which compare children born to the same mother under different exposure conditions, are one of the best tools for untangling this, and they frequently shrink or eliminate associations that looked strong in simpler analyses.
Opioids
Given the opioid crisis, the question of whether prenatal opioid exposure raises autism risk has attracted considerable research attention. The answer so far is mixed, leaning toward no clear link for typical exposure levels.
A large nationwide birth cohort study in South Korea tracked children born to mothers who used opioids during pregnancy and found that prenatal opioid exposure increased the risk of several neuropsychiatric outcomes, including attention deficit hyperactivity disorder and intellectual disability, but not autism spectrum disorder specifically.4BMJ. Prenatal opioid exposure and subsequent risk of neuropsychiatric disorders in children: nationwide birth cohort study in South Korea A retrospective cohort study similarly found no overall association between fetal opioid exposure and neurodevelopmental disorders after adjusting for confounders, though children with longer cumulative exposure or higher doses did show elevated risk.5PubMed Central. Association Between Prenatal Opioid Exposure and Neurodevelopmental Outcomes in Early Childhood: A Retrospective Cohort Study
Some evidence suggests that the timing of exposure may matter. One study found that opioid prescriptions before conception were associated with increased odds of having a child with ASD or autism-like features, while prescriptions during most pregnancy periods were not significantly linked.6PubMed Central. Brief Report: Maternal Opioid Prescription from Preconception Through Pregnancy and the Odds of Autism Spectrum Disorder and Autism Features in Children That preconception finding is curious because it raises the possibility that the mother’s underlying health condition or genetic background, rather than the drug itself, is driving the association. It is exactly the kind of result that makes researchers cautious about interpreting correlations as causes.
Alcohol
Fetal alcohol spectrum disorder is one of the best-documented consequences of prenatal substance exposure, affecting brain development in ways that can produce social difficulties, learning problems, and behavioral challenges that sometimes overlap with autism symptoms. Given that overlap, you might expect alcohol to be clearly linked to autism. It is not.
A large multi-site case-control study called SEED found no evidence that low to moderate alcohol use before or during pregnancy was associated with increased ASD risk.7PubMed Central. Prenatal Alcohol Exposure in Relation to Autism Spectrum Disorder: Findings from the Study to Explore Early Development (SEED) A separate analysis of the UK Millennium Cohort Study found a similar pattern: no statistically significant association at any level of drinking, including heavy drinking, though the point estimate for heavy drinkers did trend upward.8PubMed Central. Maternal Alcohol Consumption During Pregnancy and the Risk of Autism Spectrum Disorders in Offspring: A Retrospective Analysis of the Millennium Cohort Study The wide confidence intervals in the heavy-drinking group reflect small sample sizes, which means the study simply did not have the statistical power to rule in or rule out a modest effect at high levels of consumption.
This does not mean heavy drinking during pregnancy is safe for fetal brain development. It clearly is not. But the specific pathway from alcohol to an autism diagnosis has not been established. A review of the literature on fetal alcohol spectrum disorder and ASD noted that the two conditions share some behavioral similarities but produce controversial and inconsistent findings when researchers try to link them directly.9PubMed Central. Autism Spectrum Disorder and Fetal Alcohol Spectrum Disorder: A Literature Review Part of the confusion comes from the fact that children with heavy prenatal alcohol exposure can display social deficits and rigid behaviors that look like autism on screening tools but stem from a different underlying neurodevelopmental process. Distinguishing between the two conditions in a clinical setting requires careful evaluation. Methodological issues, including exposure misclassification and residual confounding, make the research on low to moderate drinking and neurodevelopment especially difficult to interpret.10PubMed Central. Low to Moderate Prenatal Alcohol Exposure and Neurodevelopmental Outcomes: A Narrative Review and Methodological Considerations
Cannabis
With cannabis legalization spreading, the question of whether maternal use affects autism risk is increasingly relevant. The two largest studies on this topic reach strikingly different conclusions, which tells you something about the state of the science.
A 2024 study published in JAMA Network Open followed a large cohort and found that after adjusting for maternal characteristics, prenatal cannabis use was not associated with child ASD. The finding held regardless of how frequently the mother reported using cannabis, and no difference emerged between boys and girls.11JAMA Network Open. Maternal Prenatal Cannabis Use and Child Autism Spectrum Disorder On the other hand, a data-linkage cohort study published in Psychiatry Research found a roughly threefold increased risk of ASD in children of mothers diagnosed with cannabis use disorder, with a stronger effect in boys.12PubMed. Exposure to maternal cannabis use disorder and risk of autism spectrum disorder in offspring: A data linkage cohort study
The discrepancy likely comes down to what is being measured. “Cannabis use during pregnancy” encompasses everything from occasional use to heavy, daily consumption that meets the criteria for a clinical use disorder. The JAMA study captured a broader range of use patterns and found no overall signal. The Psychiatry Research study specifically looked at mothers with diagnosed cannabis use disorder, which represents the more extreme end of the spectrum. It is plausible that heavy, chronic use has different biological effects than occasional use, but it is also plausible that women with diagnosed use disorders differ from occasional users in many other ways, including co-occurring psychiatric conditions and polydrug use, that could confound the results.
Cocaine and Methamphetamine
The evidence on stimulants like cocaine and methamphetamine is older and thinner than the data on opioids or alcohol. An early study of children with perinatal cocaine exposure found language delays in 94% and a strikingly high rate of autism at about 11%, a rate the authors noted was not seen in children exposed to alcohol or opiates alone.13PubMed Central. Autism and developmental abnormalities in children with perinatal cocaine exposure That study was small, and the field has not replicated the finding in large, well-controlled cohorts. Still, it remains one of the more alarming signals in the prenatal exposure literature.
Prenatal methamphetamine exposure has been linked to a pattern of decreased arousal, increased physiological stress, and poor quality of movement in newborns, with dose-response relationships that suggest genuine neurotoxic effects.14PubMed Central. Prenatal methamphetamine use and neonatal neurobehavioral outcome These neonatal effects are concerning, but neonatal stress and poor motor quality do not automatically translate into an autism diagnosis years later. The long-term studies that would connect the dots simply have not been done at the scale needed. Stimulant research is hampered by the same confounding issues that plague all prenatal exposure studies, compounded by the fact that heavy stimulant use during pregnancy often co-occurs with chaotic living environments, poor prenatal care, and use of other substances.
Benzodiazepines and Prescription Sedatives
Prescription sedatives like benzodiazepines are sometimes used during pregnancy for anxiety or sleep disorders, raising questions about their safety. Initial population-level studies suggested a possible association with autism and ADHD, but more rigorous designs have largely dismantled that signal.
A study using sibling comparison models, which are among the best tools for controlling for family-level confounding, found no significant association between prenatal benzodiazepine exposure during any trimester and either ASD or ADHD.15PubMed Central. Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders A systematic review of the broader literature on benzodiazepines and neurodevelopment reached a similarly cautious conclusion: while some associations popped up, the research was too scarce and methodologically inconsistent to draw firm conclusions, particularly once confounding by indication was considered.16PubMed. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: A systematic review “Confounding by indication” is the issue that women who take benzodiazepines during pregnancy tend to have anxiety disorders, and anxiety disorders themselves share genetic architecture with autism. The drug may be a bystander.
Valproic Acid as a Reference Point
While recreational drugs have not been convincingly shown to cause autism, one prescription drug has been clearly linked to it: valproic acid, an anti-epileptic medication. Prenatal exposure to valproic acid increases the prevalence of neurodevelopmental problems including autism and ADHD, and the mechanism is well enough understood that valproic acid exposure in rodents has become a standard laboratory model for studying autism-like behavior.17PubMed Central. Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review 18The FASEB Journal. Anti‐Epileptic Drug and Teratogen Valproic Acid Induces Microglial Cell Death in a Valproic Acid Murine Model of Autism
Valproic acid matters to this discussion because it demonstrates that prenatal chemical exposure can, in principle, alter brain development in ways that produce autism. It works through several pathways, including disrupting how genes are activated and deactivated during fetal brain development. But knowing that one specific drug at known doses through identified mechanisms can trigger the condition does not mean that every psychoactive substance does the same thing. The mechanisms of action are different, the doses involved are different, and the developmental windows affected are different. Valproic acid serves as proof of concept, not proof of generalization.
When Exposure Happens May Matter More Than Whether It Happens
The fetal brain does not develop on a flat timeline. Different structures and systems come online at different points, and disrupting the process during a particularly sensitive window can have outsized effects. Research on timing has found that different substances seem to carry risk during different periods. One analysis found that childhood psychopathology symptoms were specifically linked to pre-awareness alcohol exposure (before the mother knew she was pregnant) and post-awareness cannabis exposure, while the reverse timings showed no significant associations for either substance.19PubMed. Developmental windows of vulnerability: Substance-specific effects of prenatal exposure timing on child psychopathology Tobacco exposure, by contrast, carried modest risk regardless of timing.
These timing-specific patterns reinforce the idea that blanket statements about “drugs and autism” miss the mark. Different substances interact with different biological systems, and the fetus’s vulnerability to those interactions shifts throughout pregnancy. Early pregnancy, when many fundamental brain structures are being laid down, may be critical for some exposures, while later pregnancy, when neural connections are being refined, may be the vulnerable window for others.
The Paternal Side
Most research focuses on maternal drug use for the straightforward reason that the fetus develops inside the mother. But there is growing interest in whether a father’s substance use before conception could also influence offspring risk through epigenetic changes to sperm. The field is still young, but the early findings are worth watching.
A study found that THC and nicotine exposure altered DNA methylation patterns in human sperm, and that genes associated with autism were especially vulnerable to these changes because of a particular structural feature of their genetic packaging.20Scientific Reports. Sperm DNA methylation altered by THC and nicotine: Vulnerability of neurodevelopmental genes with bivalent chromatin Separate work identified a set of over 800 methylation differences in the sperm of fathers whose children went on to develop autism, suggesting that something about paternal exposures or biology is leaving a detectable mark on sperm that correlates with offspring risk.21PubMed Central. Sperm DNA methylation epimutation biomarker for paternal offspring autism susceptibility A broader review confirmed that parental substance use, from both mothers and fathers, may alter how genes are expressed in offspring without changing the underlying DNA sequence.22PubMed Central. An epigenetic synopsis of parental substance use
This is genuinely new territory. We are far from being able to say that a father’s drug use causes autism in his children. But the idea that substance exposure can leave chemical bookmarks on DNA that get passed to the next generation is biologically plausible and increasingly supported by data. It shifts the conversation beyond maternal behavior and into a broader understanding of how both parents’ exposures might shape neurodevelopmental outcomes.
Stigma and the Practical Reality
Questions about drugs and autism do not exist in a vacuum. There is enormous stigma around substance use during pregnancy, and that stigma has real consequences for how pregnant people interact with healthcare. Research has documented that stigma toward people who use drugs characterizes addiction as a moral weakness, undermines feelings of self-worth, and discourages help-seeking, even though most pregnant people who use substances reduce or stop using when they learn they are pregnant.23PubMed Central. Substance Use in Pregnancy: Identifying Stigma and Improving Care
If a parent’s substance use before or during pregnancy did contribute to their child’s autism, the child’s needs remain the same regardless of cause. Autism requires support, not blame. And from a prevention standpoint, the most effective approach is reducing barriers to prenatal care and substance use treatment rather than adding more shame to a situation already saturated with it. The science, such as it is, does not support telling parents that their drug use caused their child’s autism. What it supports is the broader, less dramatic recommendation that minimizing substance exposure during pregnancy is one of many things that can promote healthy fetal brain development.
Animal Studies and the Question of Reversibility
One of the more hopeful threads in this research comes from animal experiments on environmental enrichment, the practice of raising animals in stimulating environments with novel objects, social interaction, and opportunities for exploration. In rodent models of prenatal substance exposure, enriched environments have reversed some of the cognitive and behavioral deficits caused by the exposure.
Rats exposed to alcohol prenatally showed improvements in impulsivity and sustained attention when raised in enriched environments.24PubMed Central. Environmental enrichment reverses prenatal ethanol exposure-induced attention-deficits in rats In a separate experiment, mice prenatally exposed to aripiprazole, a pharmaceutical that disrupted their hippocampal development, showed reversal of cognitive deficits and restoration of structural changes in brain cells after environmental enrichment.25Translational Psychiatry. Environmental enrichment improves deficits in hippocampal neuroplasticity and cognition in prenatally aripiprazole-exposed mouse offspring These are rodent findings, and they do not translate directly to human autism. But they point toward a principle that matters for families: early postnatal environments can meaningfully modify outcomes that were set in motion before birth. The developing brain retains more plasticity than a simple exposure-equals-outcome model would suggest.